The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour.

Cytotoxic microspheres have been developed for intra-arterial use in patients with liver metastases. Following injection, the distribution of microspheres reflects the pattern of hepatic arterial blood-flow. Vasoactive agents, such as angiotensin II, by producing vasoconstriction in normal liver, mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldberg, J. A., Murray, T., Kerr, D. J., Willmott, N., Bessent, R. G., McKillop, J. H., McArdle, C. S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971787/
https://www.ncbi.nlm.nih.gov/pubmed/1997111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971787/
https://www.ncbi.nlm.nih.gov/pubmed/1997111

Ejemplares similares